Unlock 20% Off Global Market Reports Using Code ONLINE20 – Stay Informed on Trade Policies, Market Growth, and Key Disruptors
How Is the Microbiome Market Growth Forecast from 2025 to 2029?
The microbiome market size has grown exponentially in recent years. It will grow from $0.68 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to increased need for immunology, increasing collaborations, government initiatives, increased healthcare expenditure and growth in the number of healthcare facilities.
The microbiome market size is expected to see rapid growth in the next few years. It will grow to $1.43 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to rise in healthcare expenditure, rising requirement for customized medicine, increasing funding, technological advances and rising prevalence of chronic diseases. Major trends in the forecast period include use of artificial intelligence, strategic collaborations and agreements, boost revenues and establish category leadership, increasing the number of pipeline studies to develop microbiome therapeutics to treat different diseases, consider investing in the development of oncology microbiome therapeutics and to improve productivity, efficiency and accuracy of the precision technologies.
Claim your free report sample now:
Which Major Growth Factors Are Shaping the Microbiome Market?
The increasing prevalence of inflammatory bowel disease (IBD) is a key factor driving the growth of the microbiome market going forward. Inflammatory bowel disease (IBD) refers to a group of chronic inflammatory disorders that affect the digestive tract, primarily the gastrointestinal (GI) tract the inflammatory bowel disease has placed a spotlight on the gut microbiome's role in the disease. This has led to a surge in research, diagnostics, and therapies focused on the microbiome, driving the microbiome market's growth. For instance, in September 2022, according to the American Gastroenterological Association (AGA), a US-based medical association of gastroenterologists, 40% of Americans have halted their daily routines due to uncomfortable bowel symptoms. Meanwhile, 60-70 million Americans struggle with gastrointestinal diseases that significantly disrupt their lives. Therefore, the increasing prevalence of inflammatory bowel disease (IBD) is expected to drive the growth of the microbiome market.
Which Segment Offers the Highest Growth Opportunities in the Microbiome Market?
The microbiome market covered in this report is segmented –
1) By Type: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
4) By Technology: Genomics, Proteomics, Metabolomics
3) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases
Subsegments:
1) By Bacteria: Probiotic Bacteria, Pathogenic Bacteria, Environmental Bacteria, Bacterial Communities In Various Ecosystems
2) By Archaea: Methanogens, Halophiles, Acidophiles, Other Extremophiles
3) By Viruses: Bacteriophages, Eukaryotic Viruses, Environmental Viruses
4) By Other Microbiomes: Fungi, Protists, Helminths, Mycobiome
What Are the Key Industry Trends Transforming the Microbiome Market?
The growing technological improvement is a major trend gaining popularity in the microbiome market. Major companies in the microbiome sector are focusing on developing advanced technology solutions for microbiomes. For instance, Seed, a new microbiome company, has introduced Probiotic and Prebiotic Daily Synbiotic for both females and males. The Daily Synbiotic Seed is the first to follow a microbe-system strategy with strain-specific advantages beyond digestive health such as cardiac safety, dermatological health, immune control, reproductive health, the integrity of the gut barrier, and oxidative stress.
Who Are the Key Players Driving the Microbiome Market?
Major companies operating in the microbiome market include Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc, Locus Biosciences, Osel Inc., Xbiome Co., Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd, BugSpeaks, KINS Co., Ltd, Yeda Research and Development Co. Ltd, China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, OpenBiome, Microbiome Insights Inc., Lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome
Get the full microbiome market report here:
What Are the Regional Insights for the Microbiome Market Forecast?
North America was the largest region in the microbiome market in 2024. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment